Taken together, sufficient evidence, from the physiological, cellular and molecular levels, supports claims that the anti-cancer peptide LVTX-8 could inhibit cell apoptosis and migration, by regulating the expression of p53 and cadherin-related genes. This evidence concerns the gene CDH17 and cancer.